Modulation of DNA topoisomerase II activity and expression in melanoma cells with acquired drug resistance

H Lage, H Helmbach, M Dietel, D Schadendorf

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

The role of DNA topoisomerases (Topo) IIalpha and IIbeta was investigated in various drug-resistant melanoma cells. Melanoma cells resistant to etoposide, exhibited an up to tenfold reduced Topo II activity corresponding to an increasing degree of drug resistance indicating that modulation of Topo II activity contribute to the drug-resistant phenotype. The reduction of Topo II activity was reflected by decreased nuclear amounts of both Topo II isoforms.

Original languageEnglish
Pages (from-to)488-91
Number of pages4
JournalBritish Journal of Cancer
Volume82
Issue number2
DOIs
Publication statusPublished - Jan 2000

Keywords

  • Antineoplastic Agents, Phytogenic
  • Base Sequence
  • DNA Primers
  • DNA Topoisomerases, Type II
  • Drug Resistance, Neoplasm
  • Etoposide
  • Humans
  • Melanoma
  • Molecular Sequence Data
  • Protein Isoforms
  • Tumor Cells, Cultured

Fingerprint

Dive into the research topics of 'Modulation of DNA topoisomerase II activity and expression in melanoma cells with acquired drug resistance'. Together they form a unique fingerprint.

Cite this